231 related articles for article (PubMed ID: 35505944)
61. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
[TBL] [Abstract][Full Text] [Related]
62. Eosinophilic esophagitis in children: doubts and future perspectives.
Cavalli E; Brusaferro A; Pieri ES; Cozzali R; Farinelli E; De' Angelis GL; Esposito S
J Transl Med; 2019 Aug; 17(1):262. PubMed ID: 31399124
[TBL] [Abstract][Full Text] [Related]
63. Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis.
Ahmet A; Benchimol EI; Goldbloom EB; Barkey JL
Allergy Asthma Clin Immunol; 2016; 12():49. PubMed ID: 27766109
[TBL] [Abstract][Full Text] [Related]
64. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
[TBL] [Abstract][Full Text] [Related]
65. Eosinophilic esophagitis: from pathophysiology to management.
Ghisa M; Laserra G; Maniero D; Marabotto E; Barberio B; Pelizzaro F; Barbuscio I; Zingone F; Savarino V; Savarino E
Minerva Gastroenterol (Torino); 2022 Mar; 68(1):40-48. PubMed ID: 33267562
[TBL] [Abstract][Full Text] [Related]
66. Variability in Swallowed Topical Corticosteroid Practice Patterns for Treatment of Pediatric Eosinophilic Esophagitis.
Syverson EP; Tobin M; Patton T; Franciosi JP; Gupta SK; Venkatesh RD
J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):256-259. PubMed ID: 37204839
[TBL] [Abstract][Full Text] [Related]
67. [Eosinophilic esophagitis: update 2012].
Jo Y
Korean J Gastroenterol; 2012 Jul; 60(1):3-12. PubMed ID: 22832794
[TBL] [Abstract][Full Text] [Related]
68. Eosinophilic esophagitis in pediatric age, state of the art and review of the literature.
Iuliano S; Minelli R; Vincenzi F; Gaiani F; Ruberto C; Leandro G; Bizzarri B; Nouvenne A; Di Mario F; De'Angelis GL
Acta Biomed; 2018 Dec; 89(8-S):20-26. PubMed ID: 30561413
[TBL] [Abstract][Full Text] [Related]
69. Relapse of Eosinophilic Esophagitis on Dupilumab.
Buendia MA; Choksi YA; Hiremath G
JPGN Rep; 2022 Nov; 3(4):e273. PubMed ID: 37168482
[TBL] [Abstract][Full Text] [Related]
70. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.
Lucendo AJ; Miehlke S; Schlag C; Vieth M; von Arnim U; Molina-Infante J; Hartmann D; Bredenoord AJ; Ciriza de Los Rios C; Schubert S; Brückner S; Madisch A; Hayat J; Tack J; Attwood S; Mueller R; Greinwald R; Schoepfer A; Straumann A;
Gastroenterology; 2019 Jul; 157(1):74-86.e15. PubMed ID: 30922997
[TBL] [Abstract][Full Text] [Related]
71. Eosinophilic esophagitis: New molecules, better life?
Lam AY; Ma C; Lee JK; Bredenoord AJ
Curr Opin Pharmacol; 2022 Apr; 63():102183. PubMed ID: 35176546
[TBL] [Abstract][Full Text] [Related]
72. Medical and dietary management of eosinophilic esophagitis.
Nhu QM; Aceves SS
Ann Allergy Asthma Immunol; 2018 Aug; 121(2):156-161. PubMed ID: 29753831
[TBL] [Abstract][Full Text] [Related]
73. Diagnosis and Treatment of Eosinophilic Esophagitis in Adults.
Kavitt RT; Hirano I; Vaezi MF
Am J Med; 2016 Sep; 129(9):924-34. PubMed ID: 27155108
[TBL] [Abstract][Full Text] [Related]
74. Eosinophilic Esophagitis: Etiology and Therapy.
Patel RV; Hirano I; Gonsalves N
Annu Rev Med; 2021 Jan; 72():183-197. PubMed ID: 33228437
[TBL] [Abstract][Full Text] [Related]
75. Comparison of viscous budesonide and fluticasone in the treatment of patients with eosinophilic esophagitis: a systematic review and meta-analysis.
Numan L; Kalot MA; Brotherton T; Tarakji A; Hamdeh S
Ann Gastroenterol; 2023; 36(5):511-516. PubMed ID: 37664238
[TBL] [Abstract][Full Text] [Related]
76. Histological remission of eosinophilic esophagitis under asthma therapy with IL-5 receptor monoclonal antibody: A case report.
Huguenot M; Bruhm AC; Essig M
World J Clin Cases; 2022 May; 10(14):4502-4508. PubMed ID: 35663093
[TBL] [Abstract][Full Text] [Related]
77. Eosinophilic esophagitis: review of nonsurgical treatment modalities.
Reddy V; Ghaffari G
Allergy Asthma Proc; 2013; 34(5):421-6. PubMed ID: 23998238
[TBL] [Abstract][Full Text] [Related]
78. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.
Straumann A; Lucendo AJ; Miehlke S; Vieth M; Schlag C; Biedermann L; Vaquero CS; Ciriza de Los Rios C; Schmoecker C; Madisch A; Hruz P; Hayat J; von Arnim U; Bredenoord AJ; Schubert S; Mueller R; Greinwald R; Schoepfer A; Attwood S;
Gastroenterology; 2020 Nov; 159(5):1672-1685.e5. PubMed ID: 32721437
[TBL] [Abstract][Full Text] [Related]
79. A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature.
Warzecha J; Dziekiewicz M; Bieńkowska-Tokarczyk A; Małecki M; Banaszkiewicz A
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431208
[TBL] [Abstract][Full Text] [Related]
80. Esophagitis in Adolescents.
Putnam PE
Adolesc Med State Art Rev; 2016; 27(1):1-18. PubMed ID: 27363230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
